INVO Return on Sales from 2010 to 2024
INVO Stock | USD 1.24 0.13 9.49% |
Check INVO Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among INVO main balance sheet or income statement drivers, such as Depreciation And Amortization of 210.9 K, Interest Expense of 618.1 K or Selling General Administrative of 8.5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.66, Dividend Yield of 0.0 or PTB Ratio of 2.49. INVO financial statements analysis is a perfect complement when working with INVO Bioscience Valuation or Volatility modules.
INVO | Return on Sales |
About INVO Bioscience Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include INVO Bioscience income statement, its balance sheet, and the statement of cash flows. INVO Bioscience investors use historical funamental indicators, such as INVO Bioscience's Return on Sales, to determine how well the company is positioned to perform in the future. Although INVO Bioscience investors may use each financial statement separately, they are all related. The changes in INVO Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on INVO Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on INVO Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in INVO Bioscience. Please read more on our technical analysis and fundamental analysis pages.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. The company was founded in 2007 and is based in Sarasota, Florida. Invo Bioscience operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards INVO Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, INVO Bioscience's short interest history, or implied volatility extrapolated from INVO Bioscience options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of INVO Bioscience Correlation against competitors. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.13) | Revenue Per Share 1.929 | Quarterly Revenue Growth 3.968 | Return On Assets (0.34) | Return On Equity (10.61) |
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.